ArticleFrontiers in bioengineering and biotechnology2025
The stabilizing potential of the supraspinatus is inhibited in tear-associated scapula shapes but can be modulated by kinematic adjustments.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Specific scapula shapes are associated with full-thickness tears of the supraspinatus tendon. A primary role of the supraspinatus is to actively stabilize the glenohumeral joint against muscles that generate destabilizing shear forces. Mechanisms that increase the supraspinatus load required to perform this stabilizing function may increase an individual's susceptibility to tears. Previous work has shown that tear-associated scapula shapes increase the destabilizing action of the deltoid during arm-raising, but no work has investigated whether tear-associated shapes inhibit the stabilizing potential of the supraspinatus itself. Methods: We combined statistical shape modeling, kinematics-driven simulations of the glenohumeral joint, and a finite element model of the supraspinatus to investigate the interactions among shape, kinematics, and the stabilizing potential of the supraspinatus. First, we identified tear-associated 3D scapula shapes using partial least squares discriminant analysis. Second, we examined how tear-associated shapes alter the stabilizing potential of the supraspinatus given the same kinematic path. Finally, we examined the extent to which kinematic perturbations could modulate differences in stabilizing potential. Results: Relative to asymptomatic controls, individuals with full-thickness tears possessed a suite of 3D shape differences including narrower supraspinous fossae and anteverted glenoids. For the same abduction path, tear-associated scapula shapes caused supraspinatus fibres to act more anteriorly and less compressively compared to the control shapes, potentially inhibiting the supraspinatus' ability to stabilize the humeral head. When the abduction path of the tear-associated scapula was internally rotated and shifted anteriorly, the supraspinatus line-of-action closely resembled that of the control-associated scapula; however, the tear-associated shape still possessed a narrower breadth in its supraspinatus line-of-action. Discussion: Our findings indicate that tear-associated scapula geometry may inhibit the stabilizing potential of the supraspinatus, but this shape-driven change could be partially modulated when the abduction path of the tear-associated shape was perturbed. The magnitude of kinematic perturbations required to modulate function exceeded the magnitude of shape differences, indicating that the perturbations are not correcting for a simple offset, but rather complex changes in muscle geometry that occur due to 3D shape differences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.